Kristin Hatcher

Kristin Hatcher is a dedicated advocate for drug development and education, known for her impactful work in both fields. With a background in pharmaceutical sciences and education, Kristin has dedicated her career to bridging the gap between research and practical application, ensuring that advancements in drug development translate into real-world benefits.Through her advocacy in drug development, Kristin actively collaborates with patients, pharmaceutical companies, researchers, and health organizations to promote innovative treatments and therapies.She is passionate about addressing unmet medical needs and works tirelessly to advocate for policies that support research funding and accessibility to new therapeutics.Her efforts focus on ensuring that patients receive timely and equitable access to life-saving treatments.Prior to joining United Liver, Kristin was the Deputy Director of Operations at COMBINEDBrain, a consortium of over 100 rare, genetic, neurological pediatric patient-related advocacy groups with the mission of effectively and efficiently capturing biomarkers and defining outcome measures to expedite and enhance research efforts in rare diseases.During her time at COMBINEDBrain, she developed a passion for the patient role in drug development, a love of the use of data to gain insight into patient perspectives, and learned the power of combining efforts in the rare diseases community to speed the pathway to treatment and cures.As the oldest living diagnosed Alpha-1 MZ patient in her family, her goal is to also be the first Alpha-1 MZ patient in her family to make it to 65 year old. When she isn't advocating for rare diseases, she enjoys traveling with her husband, visiting her grown daughter, playing with her beloved Golden Doodle, talking to her millions of girlfriends, catching up with her former students and mentees, practicing yoga, and volunteering for Tennessee Voices for Victims.